Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

Trial Profile

Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Beclometasone (Primary) ; Dexamethasone
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 08 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top